TrialVaccine2023

Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1-uninfected adult participants in the US.

Hong-Van Tieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.